- Become aware of how SGLT2 inhibitors work to reduce CV mortality.
- Become aware of how SGLT2 inhibitors may slow kidney disease progression.
- Become aware of adverse events from chronic use.
Monday, September 25, 2017 - 5:00pm to 6:00pm
George L. Bakris, M.D.
Chicago, IL 60637
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation